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PURPOSE. While basic visual functions have been described in subjects with congenital
achromatopsia (ACHM), little is known about their mid- or high-level cortical visual
processing. We compared midlevel cortical visual processing in ACHM subjects (n ¼ 11)
and controls (n ¼ 20).
METHODS. Abilities to detect global form, global motion, and biological motion embedded in
noise were tested across a range of light levels, including scotopic, in which both ACHM
subjects and controls must rely on rods. Contrast sensitivity functions (CSFs) were also
measured.
RESULTS. Achromatopsia subjects showed differential impairments across tests. In scotopic
conditions, global form was most impaired, while biological motion was normal. In a subset
of three ACHM subjects with normal scotopic CSFs, two of the three showed global form
perception worse than controls; all showed global motion comparable to controls; and
strikingly, two of the three showed biological motion perception superior to controls.
CONCLUSIONS. The cone signal appears to play a crucial role in the development of perception
of global form, as in ACHM this is impaired even in scotopic conditions, in which controls also
have to rely on rods, and even in ACHM subjects with no scotopic spatial vision loss. In
contrast, the rod signal appears sufficient for the development of normal (or even superior)
extrastriate biological motion perception. These results suggest that ACHM leads to atypical
development of cortical vision, highlighting the need to better understand the potential for
further reorganization of cortical visual processing following new therapies aimed at restoring
cone function.
Keywords: motion perception, form perception, psychophysics, biological motion, rod vision
Achromatopsia (ACHM), also known as rod monochromacy,is a stationary cone dysfunction syndrome, affecting ~1 in
30,000 people.1,2 The main symptoms are reduced visual
acuity, photophobia, and an absence of color vision from birth/
early infancy. Individuals with ACHM prefer mesopic conditions
and have normal night vision. Transmission is autosomal
recessive, and six genes have been identified: GNAT2, PDE6C,
PDE6H, ATF6, CNGA3, and CNGB3, which together account
for approximately 70% to 80% of all cases.1,3 Of these, ~70% of
cases are caused by mutations in either CNGA3 or CNGB3.4
While classified as a stationary disorder, there is evidence of
changes to the retina over time,5–7 although the extent to
which this may impact functional vision is unclear.
Previous research into visual function in ACHM has focused
on early-level visual functions such as acuity and contrast
sensitivity.2,8–15 For example, visual acuity in ACHM subjects
with CNGA3 and CNGB3 mutations has been reported in the
range of 20/100 to 20/600.16 Spatial and temporal acuity as well
as contrast sensitivity has been reported as impaired in
photopic conditions in ACHM. Under scotopic conditions,
these functions have, in some cases, been reported as
comparable to controls, suggesting typical rod-mediated basic
vision,9–11 although atypical dark adaptation curves have also
been observed.17–19
In the present study we examined for the first time midlevel
cortical visual functions in congenital ACHM, specifically, global
form, global motion, and biological motion perception. These
have all been studied extensively in both typically develop-
ing20–23 and atypical populations,24–29 and depend on extras-
triate cortical visual areas known from animal models and
human neuroimaging.25,30–36
To examine the effects of ACHM on global form and motion
processing, it is necessary to consider whether low-level
impairments of contrast sensitivity and the restriction to rod
function play a role in any reduction of sensitivity. We have
attempted to simulate these effects with normal observers by
testing global form and motion sensitivity with a diffusing
screen that acts as a low-pass filter for spatial frequencies37 and
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by testing under scotopic levels of illumination.38 Both
methods have been used and reported in previous studies:
blur39–41 and scotopic illumination.42–45 Our recent study of
global form, motion, and biological motion processing38 with
healthy controls (the same data provide a comparison for
ACHM subjects in this paper) found greater impairments in
global form perception under low light relative to global
motion and biological motion. This implies that rod vision is
relatively more efficient for processing global motion than
global form. These results imply that, compared with controls
at photopic light levels, ACHM subjects may show impairments
in form relative to motion and biological motion perception
due to a reliance on rods for vision in the latter cases. A crucial
comparison, however, is between controls and ACHM subjects
at scotopic light levels, at which both groups must rely on rods.
In scotopic conditions, ACHM subjects may differ from
controls if they have atypical rod functioning and/or have
undergone atypical visual development due to experiencing
atypical (rod-only) visual input from birth. This comparison is
the focus of the present paper.
METHODS
Subjects
Eleven subjects (mean age, 28.6; standard deviation, 7.4 years;
range, 19.6–50.0 years; 6 males/5 females) with a diagnosis of
ACHM completed the study within the Faculty of Brain
Sciences, Division of Psychology and Language Sciences,
University College London. Information sheets were provided
and informed consent was obtained before testing com-
menced. All research procedures were carried out in accor-
dance with the guidelines of the Declaration of Helsinki.
Results were compared with baseline data collected from 20
normally sighted control subjects (mean age, 25.2; standard
deviation, 4.6 years; range, 18.9–38.0 years; 11 males/9
females), which have been reported in detail elsewhere.38
Achromatopsia subjects were recruited through referrals
from their clinician (JA, MM) at Moorfields Eye Hospital. All
subjects had a diagnosis of ACHM based on both clinical
symptoms and genotyping. Details of genotype and visual
acuity for each subject can be found in the Table. Details of
contrast sensitivity and of fixation stability, recorded using a
Nidek MP-1 microperimeter (Nidek Technologies, Padova,
Italy), are also given where these test results were available.
Acuity and contrast sensitivity tests were carried out using
standard protocols and lighting conditions (85 cd/m2). Micro-
perimetry was carried out on a research basis, and results have
been published elsewhere.5
Stimulus Generation and Task Design
Stimuli were generated in MATLAB 2012 (MathWorks, Natick,
MA, USA) using the Psychophysics Toolbox extensions.46–48
Stimuli were viewed on a Mitsubishi (Tokyo, Japan) Diamond Pro
SB2070 22-inch cathode ray tube (60-Hz refresh rate) at a
distance of 60 cm with a display area of 378 3 288. This display
distance reduced the need to accommodate close up, therefore
reducing the impact of any hyperopic refractive error. Individuals
with prescription lenses wore these during the study.
Testing took approximately 1 hour per subject, with
additional time required for the dark adaptation. Each task
(form, motion, biological motion) was repeated three times in
each light condition. The contrast sensitivity task was
completed in one run in each light condition. The order of
the four tasks was randomized for each light condition;
however, the three runs of each task were always carried out
in succession so that a subject completed 90 trials of form,
motion, or biological motion consecutively.
Global Form and Motion Stimuli
Example form and motion stimuli are shown in Figure 1. These
stimuli have been used and described in previous stud-
ies.37,38,49,50 The stimuli were designed to be matched in
terms of the regions of the visual field over which form or
motion needs to be integrated.
The task was to judge which side of the display, left or right,
contained the global stimulus. Coherence of stimuli (propor-
tion of coherent, as compared with random, elements) was
varied to estimate coherence thresholds. Both the form and
motion stimuli were constructed from 2000 white dots (each 6
pixels in diameter, 0.298 visual angle) against a black
background. For the motion stimulus, dots were plotted in
successive frames along an arc trajectory, moving at 8.68/s,
with a lifetime of 133 ms. For the form stimulus, dots were
plotted simultaneously to create short line segments. Motion
trajectories and line segments could be up to eight dots in
length. For the motion stimulus, within each frame 1/8th of the
number of dots were restarted in a random location, creating a
range of trajectory lengths. In the form stimulus in which short
line segments were based on these trajectories, this created
lines ranging from one to eight dots in length, averaging 1.38.
TABLE. Demographic and Clinical Details for the 11 Achromatopsia Subjects With Established Genotypes
Subject Age Sex Genotype
Visual Acuity, logMAR
Contrast Sensitivity,
LogCS Fixation Stability, %*
Right Eye Left Eye Both Eyes Right Eye Left Eye Both Eyes Right Eye Left Eye
S1 19.6 F CNGA3 0.78 0.78 0.78 NA NA NA NA NA
S2 20.6 M CNGB3 0.88 0.86 0.82 1.35 1.35 1.5 100 87
S3 21.2 F CNGA3 0.8 0.8 0.76 0.75 0.65 0.9 100 100
S4 25.3 M CNGB3 0.72 0.8 0.64 1.75 1.55 1.85 100 96
S5 26.8 M CNGB3 0.84 0.92 0.82 1.5 1.2 1.4 99 99
S6 28.5 M CNGB3 1 1.2 1 1.05 1.15 1.35 30 27
S7 31.5 M CNGB3 0.86 0.84 0.84 1.35 1.35 1.4 85 99
S8 34 F CNGA3 0.9 0.84 0.82 1.5 1.5 1.65 91 79
S9 35.8 F CNGB3 0.88 1.1 0.88 1.05 1.1 1.2 NA NA
S10 42.3 F CNGA3 1 1 1 NA NA NA NA NA
S11 50 M CNGB3 0.92 1 0.86 1.35 1.15 1.35 100 92
* Fixation was recorded with a Nidek MP1 microperimeter. Participants were required to fixate a cross subtending 28. The number given is the
percentage of time spent fixating the central 48 surrounding the fixation target over a 30-second period.
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Motion dots and form short line segments were randomly
distributed across the display. Coherent elements were plotted
around a common center of curvature, creating a circular
structure subtending 168. Incoherent elements were randomly
oriented.
On each trial, global form or motion was plotted, at random,
on one side of the display (centered 108 from the display
center). The opposite side always contained incoherent
stimuli. Subjects were asked to fixate a central point while
stimuli were displayed for 1 second. Subjects then had as long
as they needed following this to indicate (with a button press)
via two-alternative forced choice (2AFC) on which side they
had seen the coherent pattern. The level of coherence was
varied from trial to trial according to the PSI adaptive
method.51 Subjects completed 90 trials per light level of the
form and motion tests, each made up of three runs of 30 trials.
The 75% coherence threshold was calculated for each run, and
estimated thresholds were averaged across three runs.
Biological Motion
The biological motion stimulus consisted of a point-light figure
walking on the spot (see Fig. 2). The angle of the walker
around the vertical was randomly varied from trial to trial to
reduce habituation and predictability of the stimulus. The
stimulus was generated using Cutting’s algorithm,52 creating
figures made up of 14 white dots each with a visual angle of
0.278 and subtending 15.28 3 5.78 in total. Dots moved at an
average speed of 5.88/s.
As with the form and motion test, the biological motion test
employed a 2AFC design. Biological motion was presented on
one side of the display while a scrambled version was
presented on the opposite side. Scrambled figures had the
starting positions of dots and phase of joint angles randomized.
Subjects were asked to indicate which side of the display
contained the unscrambled biological motion. Figures were
embedded within random noise dots. Noise dots moved at the
same average speed as the biological motion dots (5.88/s) and
were drawn at random from the individual motion trajectories
of biological motion dots. The proportion of signal to noise
dots varied from trial to trial based on the PSI adaptive method.
As with the form and motion tests, subjects completed 90 trials
per light condition (three runs of 30 trials) and the 75%
threshold was estimated based on the average threshold across
these three runs.
Contrast Sensitivity Test
In addition to form, motion, and biological motion, contrast
sensitivity functions (CSFs) were also measured. These
provided a measure of early-level visual processing. Contrast
sensitivity functions were measured for all controls and 9 of the
11 ACHM subjects (2 subjects were unable to attend for this
second CSF testing session). Contrast sensitivity functions were
recorded using the qCSF method,53 which is based on a
Bayesian adaptive procedure and fits the CSF by estimating four
parameters of the curve.
The qCSF test used a 2AFC procedure in which subjects
were asked to indicate the location of a Gabor patch of variable
carrier spatial frequency, set within a 68 standard deviation
Gaussian envelope matched in average luminance to the
background. The test displayed spatial frequencies within the
range of 0.56 to 13.75 cyc/deg and contrasts within the range
of 0.5% to 97% (Michelson contrast). The Gabor was always
placed at random, 108 to the left or right of central fixation.
Subjects completed 100 trials per light level.
FIGURE 1. Example stimuli for the form and motion task. Stimuli from left to right show 91%, 60%, and 24% coherence (with the global pattern
always on the right). Form stimuli are shown here, but also demonstrate the motion task in which each line segment represents the motion
trajectory of a single dot.
FIGURE 2. Example of the biological motion stimulus display at 93%, 50%, and 15% signal-to-noise ratio. Biological motion is present on the right of
these stimuli, scrambled motion on the left.
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Light Levels
Subjects completed all the tests at four light levels. These were
defined as photopic (8.7 cd/m2), high mesopic (0.8 cd/m2),
low mesopic (2.73 102 cd/m2), and scotopic (8.73 104 cd/
m2). For the global form, motion, and biological motion tests,
the reported luminances are those of the dots or lines, which
were plotted against a black background. Contrast for these
tests was kept constant at each light level at 3.24 Log Weber
Contrast (LogWC). In the case of the contrast sensitivity test
the luminance refers to the background luminance. The
different light levels were obtained using neutral density filters
(Sabre International Ltd., Reading, UK), which were placed
over the display monitor. No other light sources were present
in the room, which was also shielded from stray external light.
The order of light levels was counterbalanced so that half of
the subjects completed the high mesopic and photopic
conditions first while half completed the scotopic and low
mesopic first. All subjects were dark adapted before the tests.
Thirty minutes of dark adaptation took place before the
scotopic/low mesopic tests, and 10 minutes of adaptation took
place before the high mesopic/photopic conditions. Adapta-
tion was achieved using blackout goggles (Mindfold, Inc.,
Durango, CO, USA).
Analyses
Results from all four light level conditions are given in
Supplementary Figure S1, but to streamline our presentation
and analyses we focus here on the photopic and scotopic
conditions. The scotopic condition is crucial as it is the one in
which controls and ACHM subjects are theoretically matched
in relying only on rods, while the photopic condition is the one
that is optimal for controls.
We used 2-way repeated-measures ANOVAs to compare (log
transformed) discrimination thresholds of ACHM subjects and
controls by light level on each test. We then examined CSF
results and carried out an additional analysis on the subset of
ACHM subjects who showed normal scotopic CSFs. We used 1-
sample t-tests corrected for multiple comparisons to compare
scotopic global form, motion, and biological motion sensitivity
in these individual subjects with the group of controls.
RESULTS
Global Form, Global Motion, and Biological Motion
The Shapiro-Wilk test of normality (Supplementary Table S1)
was used to check whether coherence thresholds departed
from normal distributions in each test and subject group.
These revealed that many results were not normally distribut-
ed. Therefore, all coherence thresholds were log transformed
for further analysis. Following log transformation, none of the
data departed from a normal distribution as shown in
Supplementary Table S1. An example of the shift to a normal
distribution is given in Supplementary Figure S2, which shows
the distribution of one set of data before and after log
transformation. Group coherence thresholds, prior to log
transformation, can be seen in Supplementary Figure S1.
Figure 3 shows log behavioral thresholds for ACHM subjects
and controls in photopic and scotopic conditions. To test for
differences between groups and light levels in each test, we
used 2-way repeated-measures ANOVAs with the between-
subjects factor group (control or ACHM) and the within-
subjects factor light level (photopic or scotopic). Overall,
ACHM subjects were significantly worse than controls (main
effect of group) on the global form (F[1,29] ¼ 21.867, P <
0.001) and global motion (F[1,29] ¼ 12.878, P ¼ 0.001) tests
but not on the biological motion test (F[1,29] ¼ 2.317, P ¼
0.139). There was a significant main effect of light level on all
three tests (form: F(1,29)¼ 92.103, P < 0.001; motion: F[1,29]
¼ 29.512, P < 0.001; biological motion: F[1,29]¼ 54.971, P <
0.001), corresponding to worse performance under scotopic
conditions. There was also a significant group 3 light level
interaction for all three tests (form: F[1,29]¼ 4.666, P¼ 0.039;
motion: F[1,29]¼ 6.417, P¼ 0.017; biological motion: F[1,29]
¼ 4.657, P¼ 0.039). This suggests that light affected sensitivity
differently in the two groups. This can be seen in Figure 3, with
ACHM subjects’ thresholds increasing less markedly in
scotopic conditions than those of controls. The main
conclusions of this analysis are also supported by a direct
comparison between the three tests through conversion to z
scores (see Supplementary Fig. S3).
Contrast Sensitivity Functions
Figure 4 shows measured photopic and scotopic CSFs for each
ACHM subject. Full CSF data from all four light levels are
shown in Supplementary Figure S4. Two of the ACHM subjects
were unable to attend follow-up appointments to have their
CSFs measured, so results are given for 9 of 11 of the ACHM
subjects. The CSF curves represent log contrast sensitivity
across a range of spatial frequencies. Shaded regions represent
the 95% confidence intervals (CIs) of control data for each light
condition, while solid lines represent the individual ACHM
subjects’ results in photopic (blue) and scotopic (red)
conditions. Subjects’ CSFs falling within the 95% CI are
therefore comparable to those of controls. This was expected
only under scotopic light levels. Three ACHM subjects (S5, S7,
S10; Fig. 4, marked with † symbol) had scotopic CSFs (red
curves in Fig. 4) comparable to those of controls. Two of the
nine ACHM subjects had severe difficulties with the task, with
recordable responses only in the high mesopic condition and
no recordable responses in photopic or scotopic conditions
(S1 and S11; Fig. 4, marked with ‡ symbol). For these ACHM
subjects the CSF task was particularly difficult relative to the
midlevel tests.
Form, Motion, and Biological Motion Perception in
ACHM Subjects With Normal Scotopic CSFs
As Figure 4 shows, three of the nine ACHM subjects whose
CSFs were measured had scotopic CSFs (red curves) at least
within the control range (S5, S7, and S10; S10 had scotopic
sensitivity better than the 95% control range at low spatial
frequencies). These results show that there was considerable
variability in spatial vision in the ACHM group. Achromatopsia
subjects with scotopic CSFs comparable to those of controls
(S5, S7, and S10) had their scotopic form, motion, and
biological results further examined.
Figure 5 shows control group data in the scotopic
condition, plotted alongside the individual data from ACHM
subjects. The three ACHM subjects with scotopic CSFs
comparable to those of controls (S5, S7, and S10, marked as
O’s in Fig. 5) had elevated scotopic form thresholds compared
to controls. However, their motion and biological motion
thresholds were comparable to or better than the ACHM group
average (see Fig. 5). Their motion thresholds were within or
just outside the control 95% CI, and their biological motion
perception was notably good, with two of the three ACHM
subjects (S7 and S10) showing biological motion thresholds
better than the control 95% CI (Fig. 5).
Departures from the control 95% CI in Figure 5 are
informative, but to test stringently for significant differences
against controls in this subset of ACHM subjects, we adjusted
for the three multiple comparisons (i.e., three individuals
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considered in Fig. 5) in each test. We asked whether each
subject’s log threshold differed from the control group mean
using a 2-tailed 1-sample t-test, with a significance threshold
calculated using the Sˇida´k correction to give a family-wise type
I error rate of 0.05 (the corrected P value is 0.0170). Significant
results from these tests are indicated in Figure 5 (marked with *
symbol). As Figure 5 shows, two of three ACHM subjects
demonstrated biological motion perception superior to that of
controls in scotopic conditions (the remaining subject was
comparable to controls), and three of three demonstrated
global motion perception comparable to that of controls.
However, even in these ACHM subjects with normal scotopic
CSFs, two of three showed impaired global form perception.
Neither individual differences in CSFs (Fig. 4) nor patterns
of performance on the main tasks in those ACHM subjects with
normal scotopic CSFs (Fig. 5) are well accounted for by
differences in age or genotype (see Table). These three subjects
had ages (31.5, 26.8, and 42.3 years) within the middle of the
overall range for the ACHM group (19.6–50.0 years) and had
both CNGB3 (n¼2) and CNGA3 (n¼ 1) mutations. The ACHM
subjects with superior biological motion perception (S7 and
S10) were the older two, one with each of CNGA3 and CNGB3.
In those with minimal CSF responses (S1, S11) there is also no
consistency in age or genotype, suggesting that these factors
do not explain their results.
DISCUSSION
The study aimed to understand the impact of ACHM on
midlevel visual perception. We were particularly interested in
whether an absence of cones leads to differences in cortical
visual processing that are not explained simply by changes in
low-level visual perception. Such differences compared with
controls could be due to visual development with atypical
input.
Results showed that ACHM subjects had differential
impairments in midlevel vision across different tests. Analyses
of variance of log thresholds found most evidence for
impairments of global form and motion, rather than biological
motion. Tests in scotopic conditions in which ACHM subjects
and controls are both dependent on their rods for vision
revealed impairments in global form and motion perception
but normal biological motion perception.
These results suggest that a congenital absence of cones
allows for normal or near-normal development of some kinds
of (scotopic) midlevel visual processing, including biological
FIGURE 3. Achromatopsia and control mean log10 coherence thresholds for form, motion, and biological motion tasks under two light levels. Error
bars represent 95% confidence intervals. ANOVA results are summarized at the top of each graph: for light (photopic/scotopic), for group (control/
ACHM), and for the light3 group interaction, ***P < 0.001, **P < 0.01, *P < 0.05; n.s. nonsignificant.
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motion perception, but not others such as global form and
motion perception. It may be that an absence of cones from
birth allows for some specialization for scotopic vision.
Deficits relative to controls in scotopic conditions may be
due to two main factors. First, they could be the outcome of
atypical visual development. Second, results could be due to a
loss of rod function relative to controls. A loss of rod sensitivity
has been suggested in ACHM.16–19,54,55 We gained insight into
the extent to which there may have been such disruption from
our measures of CSFs across different light levels.
Contrast sensitivity function results showed that most
ACHM subjects had low-level deficits in spatial vision across
both photopic and scotopic light conditions. These effects did
not seem to be explained by either the age of subjects or their
genotype, which varied across both the subgroup of subjects
with normal scotopic CSF and those who showed minimal CSF
responses.
In subjects with atypical scotopic CSF results, it is possible
that there is rod dysfunction alongside cone dysfunction.
Previous detailed reports of rod function in a single subject
with ACHM described rod-mediated vision that was compara-
ble to controls.9–11 However, there is variation across
individuals. Some cases of ACHM with associated rod
dysfunction have been reported,16,54,55 and atypical dark
adaptation curves have been found.17–19 Kahn et al.54 reported
on three sisters with cone disorders caused by the CNGB3
genotype. Rod ERG revealed reduced b-wave amplitudes
indicating loss of rod function. The results of our CSF test
support the view that a majority of ACHM subjects had
associated rod dysfunction, with six of nine ACHM subjects
demonstrating reduced spatial vision at scotopic light levels.
Possible reasons for rod dysfunction in ACHM subjects may be
FIGURE 4. Contrast sensitivity functions (CSFs) for individual ACHM subjects. Solid lines represent CSFs for each light condition with blue
representing photopic results and red representing scotopic results. Shaded blue and red areas represent the 95% confidence intervals of control
data in the photopic and scotopic conditions, respectively. Subjects in the top line had CSF results below the control range. Subjects shown in the
middle line had scotopic CSFs within the normal scotopic range and are marked †. Those with no recordable response are shown in the bottom line
and marked ‡.
FIGURE 5. Form, motion, and biological motion thresholds in the
scotopic condition. Control data represent the group mean; error
bars represent the 95% confidence interval. Individual ACHM
subjects (S5, S7, and S10) who had scotopic CSFs comparable to
those of controls are plotted individually (O’s) alongside the ACHM
subjects with impaired scotopic CSFs (X’s). Subjects S5 and S10 had
significantly worse form thresholds than controls, while subjects S7
and S10 had significantly better biological motion thresholds than
controls (differences significant after correction for multiple compar-
isons are marked *).
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the result of a bystander effect in which the loss of one class of
photoreceptor contributes to the decline of other photorecep-
tors through the transfer of material through rod–cone gap
junctions.56
Most strikingly, two of the three ACHM subjects with
normal scotopic CSFs showed superior scotopic biological
motion perception compared to controls with healthy vision.
This implies that when low-level spatial vision is not impaired,
some aspects of scotopic extrastriate vision in ACHM subjects
can be better than in healthy controls. This would be explained
by a developmental specialization for visual processing using
only the rod signal. Whether this advantage for biological
motion processing has any relationship to the observation by
Sacks57 that Pingelap islanders with ACHM are as good as or
better than unaffected observers at seeing fish moving in the
water at night is an interesting question for further research.
The dissociations in global form, motion, and biological
motion processing, in which global form and motion are
impaired but biological motion less so, are in line with
evidence that the rod system may be optimized for some types
of motion perception relative to form. Rods feed into
magnocellular mechanisms within the visual cortex,58–60
which in turn support dorsal stream processing and motion
perception.61 Parvocellular pathways, which support the
perception of form via the ventral stream,62–64 receive the
majority of their input from cones,59 and it is therefore
understandable that cone disorder subjects would demonstrate
impairments in form perception. Scotopic form impairments
were still seen in two of three ACHM subjects with normal
scotopic CSFs (suggesting normal low-level vision), which
suggests atypical extrastriate processing due to development
with atypical visual input. The cone signal therefore appears to
play a crucial role in the development of perception of global
form. In contrast, three of three ACHM subjects with normal
scotopic CSFs showed global motion perception within the
normal (control) range. This suggests that the global motion
impairments seen in the main group of ACHM subjects could
be explained by limitations in spatial vision due to impairments
in rod functioning rather than by atypical development of
extrastriate processing.
The sparing of biological motion perception in ACHM
subjects follows similar findings in subjects with congenital
cataracts and amblyopia.28,65,66 These results all point toward
biological motion perception being spared when vision is
impaired. Achromatopsia, cataract, and amblyopia subjects
reported in these studies have in common substantial visual
impairment during early development. Visual development in
these ACHM subjects may therefore have specialized to optimize
detection of biological motion when visual information is sparse.
Cone dysfunction syndromes are a candidate for stem cell
and gene therapy (Ye G, et al. IOVS 2014;55:ARVO E-Abstract
837).4,67–69 The success of any new therapies will be
dependent on the plasticity of both the retina and the visual
brain to adapt to new visual input. The extent to which their
midlevel visual processing can further be reorganized—for
example, to improve the perception of global form given a
newly available cone signal—is an important open question.
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